Trinity Biotech amends credit agreement with primary lender for financial support and growth plan

From GlobeNewswire: 2024-12-24 08:33:54

Trinity Biotech plc has amended agreements with primary lender Perceptive Advisors, providing additional liquidity of $5.5 million to support its Comprehensive Transformation Plan and development of continuous glucose monitoring technology. The company also extended a deferred payment related to the acquisition of biosensor assets and granted additional warrants to Perceptive Advisors. These strategic moves aim to strengthen Trinity Biotech’s financial position and support its long-term profitability goals. With recent World Health Organization approval for manufacturing transfer, the company is well-positioned to drive growth and innovation in global diagnostics, reinforcing its commitment to shareholders and strategic objectives.



Read more at GlobeNewswire: Trinity Biotech Announces Amended Credit Agreement with